The influence of age and extensive intraductal component histology upon breast lumpectomy margin assessment as a predictor of residual tumor.

PURPOSE Young age and extensive intraductal component (EIC) histology have been shown to be associated with increased local recurrence in women treated with breast conservation therapy. This study was conducted to determine if the status of the lumpectomy specimen margin consistently predicted for residual tumor burden risk irrespective of these variables. METHODS AND MATERIALS As part of an institutional prospective approach for breast conservation therapy (BCT), 265 cases with AJCC Stage I/II carcinoma with an initial excision margin that was < or =2 mm or indeterminate were subjected to reexcision. The probability of residual tumor (+RE) was evaluated with respect to tumor size, histopathologic subtype (invasive ductal carcinoma, invasive ductal carcinoma with an EIC, and invasive lobular carcinoma), relative closeness of the measured margin, and the extent of margin positivity graded as focal, minimal, moderate, or extensive. The amount of residual tumor was graded as microscopic, small, medium, or large. All variables were analyzed for patient age < or =45 or >45 years. RESULTS There was no significant difference in the incidence of a +RE according to age < or =45 versus >45 years when the margin was >0 < or =2 mm. Of the patients aged < or =45 years, the incidence of a +RE with a margin that was positive as compared to >0 < or =2 mm was 71% vs. 23%, respectively (p = 0.002). For women >45 years old, the difference in the incidence of +RE comparing margins that were positive or >0 < or =2 mm was not significant at 50% vs. 40%, respectively (p = 0.23). For all cases in aggregate, age < or =45 years was associated with a greater incidence of +RE as compared to patients aged >45 years with the discrepant incidence of a +RE by age strata most pronounced for focally positive margins (60% vs. 18%;p< or =0.05). In a logistic regression analysis, age (per year, as a continuous variable) and an EIC histology were significantly associated with the probability of a +RE (odds ratio [OR] = 0.80, p = 0.05 and OR = 1.9, p = 0.01, respectively). Tumor size was not significant (p = 0.23). In patients with an EIC histology, margin status is generally less predictive for differences in the incidence of a +RE. Further, the overall magnitude of difference in the incidence of a +RE related to age appears to be minimized when an EIC histology is present. In contrast, for cases classified as having non-EIC histology, there is a near-linear relationship for both age strata with respect to margin status and the incidence of a +RE. When histology is classified as non-EIC, age < or =45 years is consistently associated with a greater risk of residual tumor for all margin status categories. When the extent of margin positivity was graded as focal or minimal, residual tumor was semiquantitatively estimated as a medium/large amount in 33% versus 26% of cases aged < or =45 or >45 years, respectively (p = 0.62). CONCLUSION For positive lumpectomy specimen margins, younger age is associated with an increased residual tumor risk. An EIC histology appears to be associated with an elevated risk of residual tumor irrespective of age and may undermine the predictive utility of margin status. Therefore, age and an EIC histology should be factored into risk assessments for residual tumor that rely upon margin assessment.

[1]  D. Wazer,et al.  Extent of margin positivity as a predictor for local recurrence after breast conserving irradiation. , 1999, Radiation oncology investigations.

[2]  E. Montague,et al.  Prognostic implications of age in breast cancer patients treated with tumorectomy and irradiation or with mastectomy. , 1988, International journal of radiation oncology, biology, physics.

[3]  W. Gerald,et al.  Conservative surgery and radiation therapy in breast carcinoma: local recurrence and prognostic implications. , 1989, International journal of radiation oncology, biology, physics.

[4]  A. Thor,et al.  Loss of Heterozygosity in Normal Tissue Adjacent to Breast Carcinomas , 1996, Science.

[5]  Y. Monden,et al.  Cancerous residue in breast‐conserving surgery , 1993, Journal of surgical oncology.

[6]  S. Schnitt,et al.  Pathologic predictors of early local recurrence in stage I and II breast cancer treated by primary radiation therapy , 1984, Cancer.

[7]  H. Kooy,et al.  Early breast cancer: predictors of breast recurrence for patients treated with conservative surgery and radiation therapy. , 1990, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[8]  N. Robert,et al.  Tumor margin assessment as a guide to optimal conservation surgery and irradiation in early stage breast carcinoma. , 1989, International journal of radiation oncology, biology, physics.

[9]  Catherine C. Park,et al.  The relationship between pathologic margin status and outcome after breast-conserving therapy , 1998 .

[10]  J. Vilcoq,et al.  Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow-up. , 1989, International journal of radiation oncology, biology, physics.

[11]  C. Bressac,et al.  Why are local recurrences after breast-conserving therapy more frequent in younger patients? , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  R Holland,et al.  The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  P. Glazer,et al.  Insulin-like growth factor-I receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiation. , 1997, Cancer research.

[14]  D. Wazer,et al.  Factors determining outcome for breast-conserving irradiation with margin-directed dose escalation to the tumor bed. , 1998, International journal of radiation oncology, biology, physics.

[15]  J. Peterse,et al.  The impact of tumor size and histology on local control after breast-conserving therapy. , 1988, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[16]  D. Wazer,et al.  The value of breast lumpectomy margin assessment as a predictor of residual tumor burden. , 1997, International journal of radiation oncology, biology, physics.

[17]  D. Neuberg,et al.  Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  J. Kurtz,et al.  Conservation treatment of early breast cancer: long term results and complications. , 1987, International journal of radiation oncology, biology, physics.

[19]  T. Smith,et al.  Breast conservation therapy for early stage breast carcinoma with outstanding 10-year locoregional control rates: a case for aggressive therapy to the tumor bearing quadrant. , 1993, International journal of radiation oncology, biology, physics.

[20]  B. Asselain,et al.  Age as prognostic factor in premenopausal breast carcinoma , 1993, The Lancet.

[21]  J. Hendriks,et al.  Histologic multifocality of tis, T1–2 breast carcinomas implications for clinical trials of breast‐conserving surgery , 1985, Cancer.